Daxor to Showcase Blood Volume Analysis Platform at ASN Kidney Week 2026
Key Highlights
- ➤Daxor (DXR) will exhibit its BVA platform at ASN Kidney Week 2026
- ➤ASN Kidney Week runs October 21–25, 2026, in Denver, Colorado
- ➤FDA-cleared BVA measures total blood, red blood cell, and plasma volume
- ➤Platform targets fluid overload, cardiorenal syndrome, ESRD, AKI, and dialysis management
Expert Statements
John L. Jefferies, Chief Medical Officer of Daxor
“Managing fluid balance is one of the most critical challenges in nephrology”
John L. Jefferies, Chief Medical Officer of Daxor
“BVA provides nephrologists with exact, objective volume data, replacing subjective estimations with precision measurement to optimize patient care in both inpatient and outpatient settings.”
Making its ASN debut, Daxor’s BVA(™ )technology delivers precise volume measurement to optimize fluid management and improve complex kidney care.
Key Highlights: * Commercial Presence: Daxor exhibiting at Booth #390 during ASN Kidney Week 2026 in Denver, CO (October 21–25, 2026). * Clinical Focus: Highlighting Blood Volume Analysis (BVA) to address critical fluid overload, cardiorenal syndrome, and dialysis volume management challenges. * Global Reach: Engaging with international nephrology leaders to advance data-driven precision medicine for patients with renal disease. OAK RIDGE, Tenn., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announced today it will exhibit at the American Society of Nephrology (ASN) 59th Annual Meeting and Scientific Exposition (Kidney Week 2026) at the Colorado Convention Center in Denver, Colorado, from October 21–25, 2026.
Get started
Create a free account to read the full story.